From Yahoo Finance: 2025-04-08 09:41:00

ClearBridge Investments released its first quarter 2025 investor letter, highlighting volatile stock market performance post-election. The strategy surpassed its benchmark with new ideas despite uncertainty. Glaukos Corporation (NYSE: GKOS) was emphasized, with shares losing value but showing potential. The firm expects ongoing volatility due to major policy changes.

In the first quarter 2025 investor letter, ClearBridge Small Cap Growth Strategy highlighted Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company. Glaukos Corporation (NYSE: GKOS) experienced a one-month return of -11.98% and closed at $86.07 per share on April 7, 2025.

ClearBridge Small Cap Growth Strategy added Glaukos Corporation (NYSE: GKOS) as a new investment in its Q1 2025 letter. Glaukos Corporation (NYSE: GKOS) is one of five new investments the firm held at quarter end. The company sees potential in Glaukos Corporation (NYSE: GKOS) and other stocks for delivering higher returns.

Glaukos Corporation (NYSE: GKOS) saw a 22% year-over-year growth in consolidated net sales in 2024. Despite its potential, ClearBridge Investments sees greater promise in AI stocks for higher returns. The firm believes AI stocks offer better investment opportunities compared to Glaukos Corporation (NYSE: GKOS) and suggests exploring cheaper AI stock options for potential growth.

Read more: What Makes Glaukos Corporation (GKOS) a Compelling Stock?